ABL Diagnostics notifies Advanced Biological Laboratories beneficial stake at 93.58%

• Advanced Biological Laboratories cut its stake in ABL Diagnostics below the 95% capital threshold on July 6, 2026.
• Holding fell to 15,079,346 shares, equal to 93.58% of capital.
• Voting rights stood at 29,593,719, representing 95.94% of voting rights.
• Move followed an off-market share sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein.